1. Home
  2. GKOS

GKOS

Glaukos Corporation

Logo Glaukos Corporation

Health Care

Medical/Dental Instruments

Nasdaq

as 04-19-2024 4:00pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

Founded: 1998 Country:
United States
United States
Employees: N/A City: ALISO VIEJO
Market Cap: 4.8B IPO Year: 2015
Target Price: $95.45 AVG Volume (30 days): 682.3K
Analyst Decision: Strong Buy Number of Analysts: 11
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.78 EPS Growth: N/A
52 Week Low/High: $45.38 - $102.33 Next Earning Date: 05-01-2024
Revenue: $314,711,000 Revenue Growth: 11.26%
Revenue Growth (this year): 15.6% Revenue Growth (next year): 24.83%

Share on Social Networks: